diaDexus Inc

Type: Company
Name: diaDexus Inc
First reported Jun 25 2014 - Updated Jun 25 2014 - 3 reports

diaDexus, Inc announces leadership changes

1:30pm BSTdiaDexus, Inc:Brian Ward current CEO and director on Board of Directors, will retire from company by end of 2014.Says Alexander Johnson will join on Aug. 4 as president. ... [Published Reuters UK - Jun 25 2014]
First reported May 15 2014 - Updated May 15 2014 - 1 reports

diaDexus to Present at the Jefferies 2014 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., president and chief executive officer, is scheduled ... [Published Business Wire Health News - May 15 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

diaDexus, Inc. Reports First Quarter 2014 Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the first quarter ended March 31, 2014. "In the ... [Published Business Wire Health News - May 07 2014]
First reported May 01 2014 - Updated May 01 2014 - 1 reports

diaDexus Announces Completion of Validation Cohort for the PLAC® Test for Lp-PLA2 Activity

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced completion of the validation study that it will use to support submission ... [Published Business Wire Health News - May 01 2014]
First reported Apr 29 2014 - Updated Apr 30 2014 - 1 reports

diaDexus, Inc. to Host Conference Call and Webcast May 7, 2014 to Discuss First Quarter 2014 Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Wednesday, May 7, 2014 ... [Published Business Wire Health News - Apr 29 2014]
First reported Mar 05 2014 - Updated Mar 06 2014 - 1 reports

diaDexus, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the fourth quarter and full year ended December ... [Published Business Wire Health News - Mar 05 2014]
First reported Mar 05 2014 - Updated Mar 05 2014 - 1 reports

diaDexus, Inc. Announces Exclusive U.S. Licensing Deal with Thermo Fisher Scientific to Advance Risk Prediction in Heart Failure

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced an exclusive licensing and supply agreement with Thermo Fisher Scientific ... [Published Business Wire Health News - Mar 05 2014]
First reported Feb 19 2014 - Updated Feb 19 2014 - 1 reports

diaDexus, Inc. to Host Conference Call and Webcast March 5, 2014 to Discuss Fourth Quarter and Full Year 2013 Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Wednesday, March 5, ... [Published Business Wire Health News - Feb 19 2014]

Quotes

...and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the first quarter ended March 31, 2014. "In the first quarter, diaDexus delivered $5.4 million in revenues, while continuing the sales and marketing programs that we believe position us for positive revenue growth in the second half of 2014. In addition, the recently secured laboratory services"

More Content

All (10) | News (2) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
diaDexus, Inc announces leadership changes [Published Reuters UK - Jun 25 2014]
diaDexus Announces Leadership Changes to Drive ... [Published Investor's Business Daily - Jun 25 2014]
diaDexus Announces Leadership Changes to Drive ... [Published Business Wire Health News - Jun 25 2014]
diaDexus to Present at the Jefferies 2014 Globa... [Published Business Wire Health News - May 15 2014]
diaDexus, Inc. Reports First Quarter 2014 Finan... [Published Business Wire Health News - May 07 2014]
diaDexus Announces Completion of Validation Coh... [Published Business Wire Health News - May 01 2014]
diaDexus, Inc. to Host Conference Call and Webc... [Published Business Wire Health News - Apr 29 2014]
diaDexus, Inc. Reports Fourth Quarter and Full ... [Published Business Wire Health News - Mar 05 2014]
diaDexus, Inc. Announces Exclusive U.S. Licensi... [Published Business Wire Health News - Mar 05 2014]
diaDexus, Inc. to Host Conference Call and Webc... [Published Business Wire Health News - Feb 19 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
diaDexus Announces Leadership Changes to Drive ... [Published Business Wire Health News - Jun 25 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced leadership changes designed to expedite execution of the company’s diversification ...
diaDexus to Present at the Jefferies 2014 Globa... [Published Business Wire Health News - May 15 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., president and chief executive officer, is scheduled ...
diaDexus, Inc. Reports First Quarter 2014 Finan... [Published Business Wire Health News - May 07 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the first quarter ended March 31, 2014. "In the ...
diaDexus Announces Completion of Validation Coh... [Published Business Wire Health News - May 01 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced completion of the validation study that it will use to support submission ...
diaDexus, Inc. to Host Conference Call and Webc... [Published Business Wire Health News - Apr 29 2014]
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Wednesday, May 7, 2014 ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.